Filters
Other countries
Results: 1 to 19 of 19
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Trigonocephaly (sequence analysis of FGFR1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
CR2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Atypical Hemolytic Uremic Syndrome (aHUS) Panel Centogene AG - the Rare Disease Company Germany | 23 | 25 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 754 | 562 |
|
Congenital Diarrhea and Enteropathies Panel PreventionGenetics, part of Exact Sciences United States | 241 | 157 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 525 | 338 |
|
Primary Antibody Deficiency Panel PreventionGenetics, part of Exact Sciences United States | 50 | 46 |
|
Invitae Autoinflammatory and Autoimmunity Syndromes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 226 | 154 |
|
Invitae Primary Immunodeficiency Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 603 | 446 |
|
Invitae Common Variable Immunodeficiency Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 49 | 36 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Comprehensive Thrombotic Microangiopathy NGS Panel Fulgent Genetics United States | 58 | 37 |
|
Primary Antibody Deficiency NGS Panel Fulgent Genetics United States | 102 | 37 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 473 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Results: 1 to 19 of 19
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.